COVID-19 and lombardy: TESTing the impact of the first wave of the pandemic
Article 2020 en
Authors
LP
Luca Perico
ST
Susanna Tomasoni
TP
Tobia Peracchi
Abstract
2 min read
BackgroundItaly was the first western country to experience a large Coronavirus Disease 2019 (COVID-19) outbreak and the province of Bergamo experienced one of the deadliest COVID-19 outbreaks in the world. Following the peak of the epidemic in mid-March, the curve has slowly fallen thanks to the strict lockdown imposed by the Italian government on 9th March 2020.MethodsWe performed a cross-sectional study to assess the prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in 423 workers in Bergamo province who returned to the workplace after the end of the Italian lockdown on 5th May 2020. To this end, we performed an enzyme-linked immunosorbent assay (ELISA) to detect the humoral response against SARS-CoV-2 and a nasopharyngeal swab to assess the presence of SARS-CoV-2 RNA by real-time reverse transcription polymerase chain reaction (rRT-PCR). As a secondary aim of the study, we validated a lateral flow immunochromatography assay (LFIA) for the detection of anti-SARS-CoV-2 antibodies.FindingsELISA identified 38.5% positive subjects, of whom 51.5% were positive for both IgG and IgM, 47.3% were positive only for IgG, but only 1.2% were positive for IgM alone. Only 23 (5.4%) participants tested positive for SARS-CoV-2 by rRT-PCR, although with high cycle thresholds (between 34 and 39), indicating a very low residual viral load that was not able to infect cultured cells. All these rRT-PCR positive subjects had already experienced seroconversion. When the ELISA was used as the comparator, the estimated specificity and sensitivity of the rapid LFIA for IgG were 98% and 92%, respectively.Interpretationthe prevalence of SARS-CoV-2 infection in the province of Bergamo reached 38.5%, significantly higher than has been reported for most other regions worldwide. Few nasopharyngeal swabs tested positive in fully recovered subjects, though with a very low SARS-CoV-2 viral load, with implications for infectivity and discharge policies for positive individuals in the post-pandemic period. The rapid LFIA used in this study is a valuable tool for rapid serologic surveillance of COVID-19 for population studies.FundingThe study was supported by Regione Lombardia, Milano Serravalle - Milano Tangenziali S.p.A., Brembo S.p.A, and by MEI System.
Norberto Perico, S. Fagiuoli, Fabiano Di Marco, Andrea Laghi, Roberto Cosentini, Marco Rizzi, Andrea Gianatti, Alessandro Rambaldi, Piero Ruggenenti, Carlo La Vecchia, Guido Bertolini, Stefano Paglia, Ferdinando Luca Lorini, Giuseppe Remuzzi
Narcisse Ndieugnou Djangang, Lorenzo Peluso, Marta Talamonti, Antonio Izzi, Pierre Alain Gevenois, Alessandra Garufi, Jean‐Christophe Goffard, Sophie Henrard, Paolo Severgnini, Jean Louis Vincent, Jacques Créteur, Fabio Silvio Taccone
Norberto Perico, S. Fagiuoli, Fabiano Di Marco, Andrea Laghi, Roberto Cosentini, Marco Rizzo, Andrea Gianatti, Alessandro Rambaldi, Piero Ruggenenti, Carlo La Vecchia, Guido Bertolini, Stefano Paglia, Ferdinando Luca Lorini, Giuseppe Remuzzi
Discussion(0)
No comments yet. Be the first to comment.